How many Sololar (buprenorphine) transdermal patches are included in each box?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Información sobre el empaque de Sololar

Lamento informarle que la evidencia proporcionada no contiene información específica sobre cuántos parches de Sololar (buprenorfina transdérmica) vienen por caja.

Contexto importante sobre el producto

La evidencia disponible se refiere principalmente a un producto llamado "Sololar (TD)" que, según la información de la FDA proporcionada, es en realidad una vacuna contra tétanos y difteria (Td), no un parche de buprenorfina 1. Esta vacuna se administra en dosis de 0.5 ml por inyección intramuscular.

Información general sobre parches de buprenorfina transdérmica

Aunque no puedo responder específicamente sobre Sololar como parche de buprenorfina, la literatura médica describe que los parches transdérmicos de buprenorfina:

  • Se cambian cada 7 días (una vez por semana) 2, 3, 4
  • Vienen en diferentes concentraciones: 5,10,15, y 20 mcg/hora 2, 3, 4
  • La dosis inicial recomendada para pacientes sin tolerancia a opioides es de 5 mcg/hora 2

Recomendación práctica

Para obtener información precisa sobre el número de parches por caja del producto específico que necesita, debe:

  • Consultar directamente el empaque del producto
  • Contactar al fabricante o distribuidor
  • Verificar con su farmacia
  • Revisar la información de prescripción completa del producto específico

La cantidad de parches por caja puede variar según el fabricante, el país de distribución y la presentación comercial específica.

References

2
Guideline

adult cancer pain, version 2.2025, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2025

Related Questions

What oral buprenorphine dose is equivalent to a Butrans (buprenorphine) 10 µg/hour transdermal patch?
What is Subutex (buprenorphine)?
Can I replace the transdermal buprenorphine analgesic patch a day early?
How many doses of Subutex (buprenorphine) 8 mg may be taken in a 24‑hour period?
What should be applied to the skin before placing a buprenorphine transdermal patch to prevent skin irritation?
What is the recommended diagnostic approach for bullous pemphigoid?
What is the appropriate management for a patient who develops new‑onset suicidal ideation after initiating duloxetine (Cymbalta)?
What is the most likely diagnosis in a patient with a white blood cell count of 3.6 ×10⁹/L, relative eosinophil percentage of 5.3%, absolute neutrophil count of 2.1 ×10⁹/L, and all other laboratory values within normal limits?
How long should corticosteroids be discontinued before performing a tuberculin skin test (Mantoux test)?
Can clomipramine discontinuation syndrome cause severe persistent nausea lasting three months or more?
Can petechiae ever feel raised to the touch?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.